Oncolytics Biotech® Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
August 11, 2022
Oncocyte Announces the Appointment of John Peter Gutfreund as Independent Member of Its Board of Directors Effective July 28, 2022
August 1, 2022
Related Post
-
-
Acasti Pharma Reports First Quarter 2023 Operational Results
August 11, 2022
-
Todos Medical Completes Trial Design for Tollovid(TM) Long COVID Clinical Study in Adults
August 11, 2022
-
Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis
August 11, 2022